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X inactivation—the mammalian method of X chromosome dosage compensation—is extremely stable in human
somatic cells; only fetal germ cells have a developmental program to reverse the process. The human placenta, at
term, differs from other somatic tissues, since it has the ability to reverse the X-inactivation program. To determine
whether reversal can be induced at other stages of placental development, we examined earlier placental specimens
using a cell-hybridization assay. We found that global X reactivation is also inducible in villi cells from first-trimester
spontaneous abortions but not from first-trimester elective terminations. These differences in inducibility are not
associated with detectable variation in histone H4 acetylation, DNA methylation, or XIST expression—hallmarks
of the inactivation process—so other factors must have a role. One notable feature is that the permissive cells,
unlike nonpermissive ones, have ceased to proliferate in vivo and are either beginning or in the process of pro-
grammed cell death. Cessation of mitotic proliferation also characterizes oocytes at the stage at which they undergo
X reactivation. We suggest that, along with undermethylation, the apoptotic changes accompanying cessation of
cell proliferation contribute to the reversal of inactivation, not only in placental cells, but also in oocytes entering
meiosis.
Introduction
X inactivation—the developmental program that mam-
mals use to compensate for the sex difference in numbers
of X chromosomes (Lyon 1961)—ensures that only a sin-
gle X is transcribed in cells of both sexes (reviewed by
Migeon [2002]). The other X chromosome in females—
or, for that matter, any X chromosome in excess of one
in either sex—becomes inactive. Inactivation is mediated
by the cis-acting RNA molecules, encoded by the X in-
active–specific transcript gene (XIST in humans, Xist in
other mammalian species) (Brockdorff et al. 1991; Brown
et al. 1991a, 1991b). Located within the X-inactivation
center, Xist is expressed uniquely from inactive X chro-
mosomes, is repressed on active X chromosomes, and is
both necessary and sufficient to initiate cis X inactiva-
tion. The abundant Xist transcripts bind to the X chro-
mosome from which they are transcribed (Beletskii et al.
2001) and induce the chromatin modifications along the
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chromosome, which in turn silence most genes on the
chromosome.
The process responsible for X inactivation occurs only
during embryonic development (Wutz and Jaenisch
2000) or in totipotent cells of embryonic origin (Martin
et al. 1978). Adding extra X chromosomes to a cell—
past the stage when inactivation is initiated—has no
effect (Migeon et al. 1996; authors’ unpublished ob-
servations). Once initiated, the inactive state is main-
tained consistently from one cell to its daughters during
cell division, so that all cells in a clonal population have
the same inactive X (Davidson et al. 1963). The long-
term silencing responsible for clonality is mediated by
the methylation of cytosine residues in clustered CpG
dinucleotides on the inactive X.
Piecemeal reactivation—which affects some genes but
not others—occurs in marsupials (Kaslow and Migeon
1987) and in chorionic villi (CV) of humans (Migeon et
al. 1985) and mice (Mann et al. 2004) and is associated
with demethylation of the re-expressed gene (Migeon
et al. 1985; Kaslow and Migeon 1987). Such localized
reactivation is not associated with global changes in the
chromosome; the hallmarks of an inactive X chromo-
some—late replication and chromosome condensation—
are not affected.
On the other hand, global reversal of X inactivation
is programmed to occur in female germ cells during their
differentiation into mature gametes (Chapman 1986;
Khalil et al. 2004). Nothing is known about the under-
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lying mechanisms, and most of what is known comes
from studies of mice. As they migrate from hindgut to
the germinal ridge, the primordial germ cells (PGCs)
with two X chromosomes inactivate one of them ran-
domly (McMahon et al. 1981). However, according to
McLaren (2003), the silent X is reactivated about the
time the germ cells enter the genital ridge, coincident
with the end of mitosis (the final 2–3 rounds) and the
beginning of the premeiotic stage. Although an exact
time is unknown, reactivation occurs before the PGCs
enter meiosis. Like XX germ cells in the female, the
XXY cells in males undergo reactivation in the primitive
gonad, but the male cells do not enter meiosis (Mroz
et al. 1999). It is conceivable that reactivation occurs
in response to some signal from neighboring somatic
cells of the gonad.
Somewhat analogous to X inactivation in female germ
cells is the transient inactivation of both X and Y during
spermatogenesis (Khalil et al. 2004). Although inacti-
vation of the XY body is associated with Xist tran-
scription, the Xist transcripts are not needed; even when
the Xist locus has been ablated, the XY body forms
normally in primary spermatocytes, and normal sper-
matogenesis ensues (McCarrey et al. 2002). It is not
merely coincidental that reversible inactivation in germ
cells of both sexes is associated with a lack of meth-
ylated CpG islands on the transiently inactive X at the
time that reversal occurs (Driscoll and Migeon 1990;
Ariel et al. 1994). The absence of methylation to lock
in the repression of genes on the silent X chromosome
greatly facilitates reversal of the inactive state.
Most attempts to reverse inactivation in somatic cells
by experimental manipulation have been futile. Even
removal of its X inactivation center does not affect the
silence of the inactive X (Brown and Willard 1994). Yet
piecemeal reactivation of one or several genes on the
inactive X can be induced in cultured somatic cells or
hybrids by demethylating agents (Mohandas et al. 1981)
that demethylate the CpG islands within or near the
repressed genes (Wolf et al. 1984).
To date, the placenta is the only human somatic tissue
known to be capable of global X reactivation. This or-
gan differs from all others in several features; two rele-
vant differences are instability of X inactivation and
undermethylated DNA. Some X-linked genes—subject
to inactivation in other tissues—are partially expressed
in CV, and this expression is associated with under-
methylation of the relevant CpG islands (Migeon et al.
1985, 1986).
Because of the undermethylated status of its X-linked
genes (Driscoll and Migeon 1990; Luo et al. 1993), it
is not surprising that placental cells are susceptible to
reversal of inactivation. In fact, reactivation is inducible
in human CV. Unlike the inactive X in other somatic
tissues, the inactive X in cells from term (newborn) pla-
centas can be globally reactivated when these CV cells
are hybridized with mouse A9 cells (Migeon et al. 1986).
The reactivated chromosomes are indeed active; they rep-
licate synchronously with human autosomes and fully
express genes that are usually silent on inactive X chro-
mosomes, such as G6PD, HPRT, PGK, and TIMP. Also,
reactivation is associated with repression of the XIST
gene that had been expressed previously (Luo et al. 1995).
To further explore the mechanisms involved in re-
versing X inactivation, we have extended our studies to
first-trimester placental tissues, using reactivation of the
inactive X in mouse-human cell hybrids as our assay
for reversibility. Our results show that the ability to
reverse X inactivation differs in different gestational en-
vironments and provide some insights into conditions
that promote reversal of inactivation.
Material and Methods
Cells and Clones
Placental tissue from term pregnancies (NB1, NB2, and
NB3) and from spontaneous (SP9, SP26, and SP77) and
surgical (SA14, SA52, and SA58) abortions were ob-
tained for previous studies, in accordance with a Johns
Hopkins University internal review board (IRB)–ap-
proved protocol. In all cases, surgical procedures were
performed in the absence of chemicals and for reasons
unrelated to our studies; in no case did the investigators
participate in the medical care of the subjects. The full-
term placentas (38–40-wk gestational age) and surgi-
cal placental specimens (8–13-wk gestational age) were
treated alike; taken immediately from the delivery room,
the CV were dissected away from the maternal decidual
tissues and were minced and explanted to plastic tissue
culture dishes. In the case of specimens that had been
spontaneously aborted during the first trimester, the
product of conception was obtained close to the time of
expulsion; villi were minced and explanted to culture.
In the case of SP9 specimens, the small extraembryonic
membrane was used instead of villi. Cell cultures estab-
lished from these specimens were maintained in liquid
nitrogen, and cultures were re-established just prior to
the present study.
All the placental cells were heterozygous for the com-
mon AB electrophoretic variants (Davidson et al. 1963)
of the enzyme glucose-6-phosphate dehydrogenase
(G6PD [MIM 305900]). Clones derived from single
cells, obtained by cell dilution, were assayed for these
G6PD isozymes, to identify those clones suitable for hy-
bridization (see section below). All clonal specimens had
two normal X chromosomes. The other cells were hu-
man fetal fibroblasts derived from discarded products
of conception at various gestational stages (with IRB
permission), adult female skin fibroblasts, SM# TSA1,
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Figure 1 Cellulose acetate gel electrophoresis showing the G6PD
phenotypes of placental cells and hybrids. Left, Newborn placental
and mouse parent cells: A9 mouse cells expressing G6PD M (lane 1);
human NB1 clone 1 expressing human G6PD B and the AB hetero-
dimer (lane 3); and marker, mix of A plus B isozymes (lane 2). Center,
Hybrids from term placenta, NB2. In these hybrids, G6PD B marks
the active X, and G6PD A marks the reactivated X: hybrid 1, with
reactivated X expressing G6PD A, mouse G6PD M, and the AM het-
erodimer (lane 4); hybrid 2, with active X, expressing B, mouse, and
the BM heterodimers (lane 5). Note that the BM heterodimer migrates
close to human G6PD A. Right, Hybrids from spontaneous abortus
SP9. In these hybrids, G6PD A marks the active X, and G6PD B marks
the reactivated X: hybrids 1 and 2, with both active and reactivated
X, expressing all six isozymes (lanes 6, 8, and 10); hybrid 3, with
active X expressing A, mouse, and the AM heterodimers (lane 7);
markers, mix of cells with A, B, and M (mouse) isozymes (lane 9).
Note that G6PD A overlaps the BM heterodimer.
Figure 2 Scheme showing reversibility assay. A and Bp human
G6PD isozymes; M p mouse G6PD; Xa p active X; Xi p inactive
X. G6PD B, encoded by Xi, is silent (gray B) in parent cell but ex-
pressed (black B) in hybrids. Parent clone expresses only G6PD A,
since G6PD B is on the Xi. Hybrids express G6PD M plus either G6PD
A (if they have the active X) or G6PD B (if they have a reactivated
X).
a human-mouse hybrid with an inactive X chromosome
(Migeon et al. 1995), and mouse A9 cells.
G6PD Analysis
Parental cells, clones, and derivative hybrids were an-
alyzed by cellulose acetate electrophoresis to determine
which G6PD isozyme(s) was expressed (Migeon et al.
1985). Human G6PD B, the slowest to migrate through
the electrophoretic field, is easily distinguished from the
faster-migrating G6PD A, and both move more slowly
than the mouse G6PD isozyme (G6PD M) (fig. 1, lanes
1 and 2). In hybrids, the presence of heterodimers—seen
as bands migrating in between those for A, B, and M
isozymes—means that two or more X chromosomes (i.e.,
mouse plus one or two human X chromosomes) are
being expressed in the same cell (fig. 1, lanes 4–6).
Acetylation of Histone H4
To determine the histone H4–acetylation status of the
X chromosomes, unfixed metaphase cells were labeled
by indirect immunofluorescence with rabbit anti-serum
R5/12, specific for histone H4 acetylated at lysine 12
(Jeppesen and Turner 1993; Migeon et al. 1999). To
inhibit deacetylation of H4 occurring during metaphase
arrest, and hence to ensure that even weakly acetylated
H4 domains were immunolabeled, metaphase cells from
some cultures were obtained in the presence of 4 mM
sodium butyrate. Human X chromosomes were identi-
fied by subsequent FISH by use of an X-specific alphoid
probe, as described elsewhere (Migeon et al. 1996).
XIST and TSIX Expression
RT-PCR.—Total RNA was isolated with TRIZOL (In-
vitrogen), was treated with DNaseI, and was analyzed,
as described elsewhere (Migeon et al. 2002).
RNA FISH.—Interphase cells on slides were permea-
bilized, were fixed in paraformaldehyde, were dehydrated,
and were hybridized without denaturation for 3 h, with
labeled probes and with human COT-1 and salmon sperm
DNA, as described elsewhere (Migeon et al. 2002). The
FISH probes were PCR products cloned into the pCR2.1
TOPO vector and were either TSIX or XIST specific
(Migeon et al. 2002). The XIST probe, labeled with
digoxygenin-16-dUTP, was detected with anti–digoxy-
genin-rhodamine; the TSIX probe, labeled with biotin-
11-dUTP, was detected with avidin/biotinylated anti-av-
idin; and 4,6-diamidino-2-phenylindole (DAPI) was used
as counterstain. For DNA FISH, the slides were dena-
tured prior to hybridization.
Results
Reversibility Assay
Figure 2 shows our strategy for detecting reversal of
X inactivation in human-mouse somatic cell hybrids.
The human parent cells were clonal populations (see the
“Material and Methods” section) derived from single
CV cells, heterozygous for the common G6PD AB elec-
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Table 1
Human G6PD Variants Expressed in Hybrids as an Assay for Reversal of X Inactivation in Placental Cells
STAGE, TISSUE, AND G6PD
VARIANT EXPRESSED









REACTIVATED XaA B AB Dimer A B AB Dimer
Newborn:
Villi:
NB1bCl1    19 8 7 4 63
NB2 Cl1    13 7 4 2 79
NB3 Cl1    6 3 1 2 50
NB3 Cl2    6 4 2 0 33
Spontaneous abortion, 1st trimester:
Villi:
SP77 Cl1    20 11 7 2 45
SP77 Cl2    18 8 6 4 55
SP26 Cl1    6 0 6 0 0
Membrane:
SP9 Cl1    8 1 5 2 88
SP9 Cl2    8 4 1 3 50
Surgical abortion, 1st trimester:
Villi:
SA14 Cl1    15 15 0 0 0
SA14 Cl2    17 0 17 0 0
SA58 Cl1    2 0 2 0 0
SA52 Cl1    11 0 11 0 0
NOTE.—A p only G6PD A expressed; B p only G6PD B expressed; AB Dimer p AB heterodimer expressed in the parent clone (Cl) or
derivative hybrids. The hybrids with the AB dimer were karyotyped and had two human X chromosomes.
a Percentage of hybrids that express the G6PD variant from the previously inactive X.
b NB1 hybrids were reported elsewhere (Migeon et al. 1986).
trophoretic variants (Davidson et al. 1963). Each cell in
the clone had the same active X, which could be iden-
tified by the G6PD variant it expressed. They also had
an intact locus encoding the enzyme hypoxanthine phos-
phoribosyl transferase (HPRT [MIM 308000]). The
mouse parent cells were Hprt-deficient A9. After hy-
bridization, the cells were plated into hypoxanthine-am-
ethopterin-thymidine (HAT) medium, to select for those
expressing X-linked human HPRT from an active X.
Well-isolated colonies were picked with cloning cylin-
ders, were transferred into 35-mm petri dishes, were sub-
cultured once, and were analyzed for their G6PD phe-
notype (Migeon et al. 1986). Therefore, the hybrids were
analyzed in very early subculture.
Because X inactivation is not imprinted in human pla-
cental cells and because either X can be the active X
(Migeon et al. 1985, 1986; Willemsen et al. 2002), the
clones derived from a single cell can express either G6PD
A or G6PD B (see table 1, clone SA14). The presence
of heterodimers—seen as bands migrating in between
those for A, B, and M isozymes—means that two or
more X chromosomes are being expressed in the same
cell (fig. 1, lanes 4–6).
Prior to hybridization, all the human parental cells
expressed the G6PD variant coming from the active X
(the single or stronger signal). In some clones, the AB
heterodimer was minimally expressed because of leaky
inactivation that characterizes some CV cells. In no
clone—not even in the leaky ones—was there an elec-
trophoretic signal for the G6PD isozyme encoded by the
inactive X; any enzyme synthesized from the inactive X
could be found only in the heterodimer, because such a
small amount of this monomer is made. Of importance,
at all gestational stages, heterodimers were seen only in
placental tissues and never in the tissues derived from
the embryo proper (Migeon et al. 1985).
Hybrid cells were identified by the presence of human-
mouse heterodimers (shown in fig. 1, AM [lane 4] or
BM [lane 5] or both [lanes 6, 8, and 10]). The assay
was considered positive for reversibility if the G6PD iso-
zyme encoded by the previously inactive X was being
expressed as a homodimer. It was considered negative if
the only human G6PDs expressed were the ones ex-
pressed in the human parental cell.
Cell Hybrid Assay Shows X Inactivation Is Reversible
in Placentas at Term and from First-Trimester
Spontaneous Miscarriages
Table 1 shows the results of the reversibility assay.
The enzyme expressed in the original human placental
clone marked the allele on the active X. Of the 13 human
parent clones hybridized with mouse A9 cells, 7 ex-
pressed G6PD A and 6 expressed G6PD B from their
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active X chromosome. Of the 13 clones, 5 had a less
intense G6PD AB heterodimer, which indicates leaky ex-
pression from the gene on the inactive X (fig. 1, lane 3).
After hybridization, all four full-term placental speci-
mens gave rise to hybrids expressing the G6PD allele
that was silent in the human parent clone. For example,
full-term villus NB2 clone 2 expressed only G6PD B,
but 7 of the 13 hybrids derived from this clone expressed
only G6PD A. Two of the 13 hybrids derived from NB2
clone 2 expressed the AB heterodimer, which indicates
that both human X chromosomes were present in the
hybrid and both were being expressed (table 1). AB het-
erodimers were seen in six other hybrids, even when
none was present in the parent human clone, so that
reactivation occurred even in cells initially lacking a het-
erodimer (table 1, hybrid NB2). The presence of two X
chromosomes in the hybrids with AB dimers was con-
firmed by karyotype analysis (data not shown).
Similar results were obtained in specimens from first-
trimester spontaneous abortions, associated with fetal
death in utero (table 1). Four of the five clones tested
gave rise to hybrids expressing the G6PD gene from the
X that was silent in the parent clone; 11 of 54 hybrids
expressed the G6PD AB heterodimer (fig. 1, lanes 6, 8,
and 10). Only one clone (SP26 clone 1) did not yield
many hybrids, and all of those hybrids were exactly like
the parent clone. When this culture was established in
1980, lab notes referred to the specimen as “fresh,” a
term not used to describe any other specimen in this
category. However, some clones from this specimen had
heterodimers, but the clone used for hybridization did
not. The low number of hybrids from this specimen may
account for the absence of hybrids with a reactivated X.
Hybrid Cells with Reactivated X Have Characteristics
of an Active X
Our previous studies of term placentas showed that
the hybrid cells, which expressed the G6PD allele from
the inactive X, also expressed other housekeeping genes
on that chromosome (Migeon et al. 1986). In addition,
the reactivated X replicated synchronously with the ac-
tive one. Therefore, for this study, we could use the G6PD
phenotype as an indicator of global reactivation. In sup-
port of the global reactivation of the chromosome in the
present study was our finding that the HPRT locus on
the previously silent X was also derepressed (enabling
selection in HAT medium) and the presence of acetylated
histone H4—a hallmark of active chromatin—on the
reactivated X in hybrids (fig. 3B and discussed below).
Not All Placentas Can Reverse X Inactivation
We also derived 45 hybrids from four CV specimens
from pregnancies terminated by surgical procedures,
without the use of chemicals, in the first trimester (table
1, tissues SA14, SA58, and SA52). Unlike the other pla-
cental specimens, none of the clones derived from these
specimens expressed the AB dimer. And although the
conditions of specimen procurement and cell hybridiza-
tion were the same as for term placentas, the results were
not the same. In each case, the hybrids expressed both
human and mouse G6PD enzymes and the human-
mouse heterodimer, as expected for hybrid cells. How-
ever, the human G6PD variant encoded by the inactive
X chromosome was not expressed in any of the 45
hybrids.
The Search for Factors Underlying Competence
for Reversal
Because not all CV could reverse inactivation, we
looked for features that might explain the difference be-
tween competent and incompetent cells. Our previous
studies of DNA methylation patterns in CV of full-term
placentas showed marked undermethylation both of the
tissue as a whole (Driscoll and Migeon 1990) and of the
CpG islands in every gene on the inactive X that we
studied, including HPRT, G6PD, and FMR1. Methyla-
tion analysis of placental tissues from surgical termi-
nations shows that 18 of the 20 HpaII sites within the
CpG island of the FMR1 locus on the inactive X were
completely unmethylated in all specimens of 6–14 wk
gestational age (Luo et al. 1993), and the remaining 2
sites were methylated in only a minority of cells. Even
in specimens that are unable to reverse inactivation,
there is marked hypomethylation. Therefore, differences
in reversibility cannot be attributed to global differences
in DNA methylation alone.
To explore the possibility that competence to reverse
X inactivation might be reflected in the degree of histone
acetylation, we examined histone H4 acetylation in pla-
cental cells and derivative hybrids. The extreme under-
acetylation of histone H4 is a marker of inactive chro-
matin and is one of the hallmarks of an inactive X
(Jeppesen and Turner 1993). All fibroblasts cultured from
CV, whether full term (NB1 and NB2) or elective ter-
minations (SA14 and SA58), contained inactive X chro-
mosomes indistinguishable by acetylated H4 labeling
from normal inactive X chromosomes, even when meta-
phases were prepared in the presence of sodium butyrate
to enhance any possible weak H4 acetylation. Figure 3A
shows the typical unlabeled inactive X in NB2 cells. The
studies also show that the X chromosomes in the two
hybrid clones with reactivated chromosomes had active
chromatin, on the basis of their histone H4 acetylation—
compelling evidence of the global nature of the reacti-
vation event. The pattern of histone acetylation of the
X chromosome in the hybrids with the reactivated Xs
(NB1 hybrids 1 and 2) was the same as that in the hybrid
with the original active X chromosome: in each case,
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Figure 3 A and B, Immunolabeling of newborn placental (A) and hybrid (B) cells, with an antibody to acetylated histone H4, followed
by DNA FISH. A, NB2 cells showing the active and inactive X. Both X chromosomes are labeled by the X centromere probe (red), whereas
only the active X is labeled by the antibody to acetylated histone H4. B, NB1 # A9 hybrid 1, showing that the reactivated X chromosome
(centromere labeled red) is well labeled by the antibody to acetylated histone H4, as expected for an active X. C–F, RNA FISH with XIST (red)
and TSIX (green) probes, showing that both genes are well expressed in term-placental cells (C–E) and adult female skin cells (F). C, Term CV
(NB5) cell showing normal red XIST signal; green signal not shown. D, Same as panel C, but merge of XIST (red) and TSIX (green) shows
coexpression (yellow overlap). E, 47,XXX term villi cells with two inactive X chromosomes; merge shows that they both express XIST (red)
and TSIX (green), as expected. F, 46,XX adult cell; merge shows expression of XIST (red) but no TSIX (green), as expected.
the observed R-like banding pattern is characteristic of
active X chromosomes. Figure 3B shows NB1 # A9
hybrid 1.
XIST Expression in the CV Cells
and Hybrids
There is considerable evidence that inactivation re-
quires not only XIST expression but also a sufficient
level of expression (Migeon et al. 2001). Therefore, using
RT-PCR, we looked for differences in XIST expression
between competent CV cells (term and first-trimester)
and normal somatic cells (adult and fetal) that are not
competent to reverse inactivation (data not shown). We
also compared term villi cells with fetal and adult so-
matic cells, using FISH studies with an XIST probe hy-
bridizing to XIST RNA (fig. 3C–3F and table 2). Neither
assay revealed striking differences between XIST ex-
pression in reversal-competent and -noncompetent cells.
Shown is the characteristic XIST RNA picture of the
inactive X in clones from full-term villi with two (fig.
3C and 3D) or three (fig. 3E) X chromosomes. The XIST
signal extensively overlaps the sex chromatin, as it does
in adult female cells (fig. 3F). In both assays, the XIST
signal in the villi cells from reversal-competent specimens
was the same as in female somatic cells that cannot re-
verse inactivation. We also examined the expression of
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Table 2
FISH Results of XIST and TSIX in Placental Cells, Hybrids, and Controls
CELL TYPE AND ASSAY
NO. OF CELLS WITH FISH SIGNALS
XIST DNA XIST RNA TSIX RNA
Fetal lunga (K-19) ND 37/50 26/50
Fetal livera (Fe-18) ND 41/50 18/50
Term placentab (NB5) ND 39/50 21/50
Term placenta with trisomy Xc (NBX3):
Assay 1 ND 41/50* 32/50*
Assay 2 40/50* 29/50* ND
Assay 3 41/50* 34/50* ND
Assay 4 ND 41/50* 43/50*
Adult female skin cells 46XX:
Assay 1 ND 40/50 0/50
Assay 2 ND 45/50 0/50
Hybrid with reactivated Xd (NB2 hybrid 1):
Assay 1 ND 7/50 1/50
Assay 2 ND 0/50 0/50
Assay 3 44/61 1/61 ND
Hybrid with reactivated X (NB2 hybrid 2):
Assay 1 ND 4/50 0/50
Assay 2 ND 0/59 ND
Hybrid with inactive Xe:
Assay 1 ND 22/50 0/50
Assay 2 ND 23/61 0/61
NOTE.—An asterisk (*) indicates cells with two signals. ND p not done.
a Female fetal cells with inactive X.
b Villi cells from newborn female placenta.
c Villi cells from newborn female placenta with trisomy X.
d Villi hybrids with human reactivated X.
e Nonvilli hybrid (adult female) with human inactive X.
the TSIX gene that encodes transcripts antisense to
XIST. In humans, TSIX is expressed only during ges-
tation and is repressed gradually after birth, so that adult
cells do not express it (Migeon et al. 2002). Table 2
summarizes the RNA FISH studies of relevant cells,
showing the numbers of cells with XIST and TSIX hy-
bridization signals. We found that TSIX was well ex-
pressed in CV cells at term but not in the hybrids derived
from them (table 2 and fig. 3D and 3E). In the hybrids
that showed the XIST locus by DNA FISH, the expres-
sion of both XIST and TSIX was repressed (table 2). As
expected, the inactive X in hybrids from adult female
human blood cells expressed XIST but not TSIX (table
2 and fig. 3F). From these studies, it seems that XIST and
TSIX are well expressed from the inactive X in term CV
cells but that both are repressed in their derived hybrids,
as a consequence of the reversal of X inactivation.
Discussion
Even though its developmental program is relatively
short-lived—9 mo instead of a lifetime—the placenta is
among the most important human organs, since it directs
the development of the fetus and is essential for its sur-
vival. One of the earliest tissues to differentiate, this
trophoblast-derived tissue is closer to its totipotent cell
progenitors than are most other tissues, and this may
contribute to its competency to reverse X inactivation.
In mouse embryonic stem cells, X reactivation is induc-
ible for a short while—just after inactivation is initiated
(Wutz and Jaenisch 2000), presumably because it is not
yet locked in by DNA methylation.
What are the factors permitting reversal to occur in
placental tissues but not in other somatic tissues? One
common feature of the reversal-competent cells is that
the inactive X is undermethylated. Clearly, hypomethy-
lation has to be an enabler, since it eliminates the major
mechanism serving to lock in inactivation. In noncom-
petent cells, a locus may be reactivated by a demethy-
lating event that affects the maintenance of inactivation.
However, global reversal of inactivation does not occur,
even when these cells are hybridized with mouse A9 cells;
the silent X retains its inactive state. The experimental
induction of global reactivation requires a good deal of
manipulation, which usually involves fusion with em-
bryonal carcinoma stem cells (Takagi et al. 1983; Kazu-
hiko et al. 1986; Yoshida et al. 1997).
Although hypomethylation creates a permissive en-
vironment, it is not in itself sufficient to induce reversal
of inactivation. Whereas all CV are remarkably under-
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Table 3
Characteristics of the Inactive X in Human Placental and Control Cells
SOURCE OF FEMALE CELLS














Newborn ∼40 Yes Yes Yes/yes Hypo Under
Spontaneous abortion !13 Yes Yes ND Hypo ND
Surgical abortion 8–14 No No ND Hypo Under
Fetal tissues 5–6.5 No NDc Yes/yes Methylated ND
Human adult skin … No No Yes/no Methylated Under
NOTE.—ND p not done.
a Hypo p hypomethylated like the inactive X in the other placental specimens; no apparent difference in
degree of hypomethylation.
b Under p underacetylated like a typical inactive X in adult human cells.
c No heterodimers.
methylated, not all of them are competent (table 3). Villi
from term placenta and from first-trimester spontane-
ous abortions are permissive, but those from first-tri-
mester induced terminations are not. Of interest, Mo-
handas et al. (1989), studying CV obtained from elective
terminations of pregnancy, did not observe heterodi-
mers in cultured fibroblasts, heterozygous for the G6PD
AB variants, or in two HAT-selected hybrids derived from
those cells. Since the differences in competence of pla-
cental cells were not appreciated at that time, our pre-
sent observations reconcile apparent discrepancies in the
literature.
The difference in reversibility does not seem to reflect
differences in the nature of the X-inactivation process.
The patterns of XIST expression, histone acetylation, and
CpG methylation in the term placentas did not differ
from those characteristic of an inactive X in other so-
matic cells (table 3). Since XIST is well expressed in
cells of term placentas, it is not surprising that the in-
active X was underacetylated in those cells—consistent
with the inactive state. There may be other modifica-
tions not yet examined that merit exploration, but such
differences, if any, are unlikely to change our conclu-
sions that X chromosomes, subject to reversal, have
chromatin that is transcriptionally inactive before hy-
bridization and transcriptionally active afterward.
Another factor to consider is that the milieu of the
mouse A9 cells may promote reversibility. The Xist RNA
seems to be less tightly packaged around the inactive X
chromosome in some hybrids than it is in its own cell
(Clemson et al. 1998). Yet the human inactive X from
such hybrids (derived from A9 or other mouse somatic
cells) usually remains inactive. In any case, A9 cells do
not provide the same degree of competency for all pla-
cental cells. Because the assay conditions were the same
for all specimens, the environment provided by A9 cells
is not sufficient to induce reactivation in the absence of
other permissive factors.
The most obvious difference between spontaneous and
induced abortions is that, in the former, the fetus has
expired—usually a number of days before the expulsion
of the placenta. The death of the fetus usually induces
changes in the placenta that lead to the cessation of
growth and initiation of apoptosis. Conceivably, the dif-
ference between villi that are capable of reversing in-
activation and those that cannot is related to senescence
or aging of placental tissues at term or after spontaneous
death of the fetus in utero.
The molecular mechanisms that control trophoblast
proliferation are not known, but, clearly, placental de-
velopment involves the simultaneous activity of two
processes—cell proliferation and degradation through
programmed cell death. At the time when the placenta
has its greatest growth spurt, proliferation markers are
strongly expressed. In a study of 22 placentas, 12 ob-
tained from curettage and 10 at term, it was found that
proliferation markers were strongly expressed in cyto-
trophoblast in early stages of gestation but were de-
creased in term placentas (Danihel et al. 2002). Apop-
tosis is an integral part of the developmental program
in the placenta. During implantation, apoptosis is im-
portant for tissue remodeling of the maternal decidua
and invasion by the developing embryo. Yet apoptosis
occurs throughout gestation, with frequency highest in
third-trimester placentas. There is evidence that an X-
linked inhibitor of apoptosis protects first-trimester tro-
phoblast cells from Fas-induced apoptosis (Straszewski-
Chavez et al. 2004). Further, pregnancies complicated
by fetal abnormalities are associated with increased tro-
phoblast apoptosis. Therefore, it seems that it is not only
the stage but also the state of health of the placenta that
is relevant. Conceivably, apoptotic changes associated
with term placentas and fetal wastage may be involved
in the reversal process. In the absence of DNA meth-
ylation, either proteases or the loss of other ancillary
silencing factors might destabilize X inactivation. One
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would not expect senescent or G0 somatic cells of the
embryo proper to undergo reversal of inactivation be-
cause the inactive state in these cells is locked in by
DNA methylation.
Along with undermethylation, the dual processes of
cessation of cell proliferation and onset of apoptosis are
also a part of the program of oocyte development. At
day 13 of mouse gestation, when male and female germ
cells are undergoing mitotic arrest or entry into meiosis,
respectively, and when X reactivation has just occurred,
apoptotic germ cells are seen for the first time. This
programmed cell death continues throughout gestation
and is responsible for the loss of a substantial proportion
of germ cells before birth. (Coucouvanis et al. 1993).
In summary, we show that not all CV cells are capable
of global X reactivation and thereby provide insights
into the conditions required for reversal. Our studies
preclude obvious differences in levels of DNA methyla-
tion, H4 acetylation, and XIST expression and suggest
that, along with hypomethylation, factors present at the
cessation of proliferation and/or at the initiation of ap-
optosis provide a cell environment permissive for re-
activation. The nature of the signals remains to be de-
termined. We suggest that it might be identified by com-
paring villi in early pregnancy with those at term, per-
haps by microarray analysis of proteins involved in cell
proliferation and in the apoptotic pathway. In addition,
attempts to induce reversal in noncompetent villi cells
may shed further light on the process.
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